Navamedic ASA Cash Flow Conversion Efficiency

Latest as of June 2026: 0.019x

Navamedic ASA cash flow conversion efficiency. Based on the latest financial reports, Navamedic ASA (NAVA) has a cash flow conversion efficiency ratio of 0.019x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr5.69 Million ≈ $598.86K USD) by net assets (Nkr306.09 Million ≈ $32.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Navamedic ASA (2003–2025)

Cash flow conversion efficiency of Navamedic ASA from 2003 to 2025. This chart illustrates how Navamedic ASA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View NAVA stock price for real-time trading data and today's change.

Navamedic ASA Cash Flow Conversion Ratio Explained

Navamedic ASA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Navamedic ASA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Navamedic ASA ranked by their cash flow conversion efficiency. Also see Navamedic ASA market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Epitomee Medical Ltd
TA:EPIT
-0.416x
Pasdec Holdings Bhd
KLSE:6912
-0.022x
TPC Mechatronics Corporation
KQ:048770
-0.010x
Profoto Holding AB
ST:PRFO
0.022x
Beyaz Filo Oto Kiralama AS
IS:BEYAZ
0.347x
MicroAlgo Inc.
NASDAQ:MLGO
0.006x
ML System S.A.
WAR:MLS
-0.076x
Apollo Power Ltd
TA:APLP
-0.100x

Annual Cash Flow Conversion Efficiency for Navamedic ASA (2003–2025)

The table below shows the annual cash flow conversion efficiency of Navamedic ASA from 2003 to 2025. Review Navamedic ASA (NAVA) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Nkr334.08 Million
≈ $35.15 Million
Nkr25.59 Million
≈ $2.69 Million
0.077x -53.21%
2024-12-31 Nkr240.44 Million
≈ $25.30 Million
Nkr39.35 Million
≈ $4.14 Million
0.164x +1570.51%
2023-12-31 Nkr222.39 Million
≈ $23.40 Million
Nkr2.18 Million
≈ $229.29K
0.010x -88.55%
2022-12-31 Nkr209.72 Million
≈ $22.07 Million
Nkr17.94 Million
≈ $1.89 Million
0.086x +1095.23%
2021-12-31 Nkr151.24 Million
≈ $15.91 Million
Nkr-1.30 Million
≈ $-136.80K
-0.009x +65.00%
2020-12-31 Nkr129.49 Million
≈ $13.63 Million
Nkr-3.18 Million
≈ $-334.63K
-0.025x -115.29%
2019-12-31 Nkr79.23 Million
≈ $8.34 Million
Nkr12.72 Million
≈ $1.34 Million
0.161x +144.27%
2018-12-31 Nkr99.32 Million
≈ $10.45 Million
Nkr-36.02 Million
≈ $-3.79 Million
-0.363x -159.37%
2017-12-31 Nkr96.70 Million
≈ $10.18 Million
Nkr59.07 Million
≈ $6.22 Million
0.611x +545.20%
2016-12-31 Nkr105.73 Million
≈ $11.13 Million
Nkr-14.51 Million
≈ $-1.53 Million
-0.137x -171.72%
2015-12-31 Nkr118.28 Million
≈ $12.45 Million
Nkr22.63 Million
≈ $2.38 Million
0.191x +297.98%
2014-12-31 Nkr111.23 Million
≈ $11.70 Million
Nkr-10.75 Million
≈ $-1.13 Million
-0.097x +33.78%
2013-12-31 Nkr107.26 Million
≈ $11.29 Million
Nkr-15.65 Million
≈ $-1.65 Million
-0.146x -117.92%
2012-12-31 Nkr96.68 Million
≈ $10.17 Million
Nkr-6.47 Million
≈ $-681.19K
-0.067x -6435.86%
2011-12-31 Nkr93.24 Million
≈ $9.81 Million
Nkr-95.52K
≈ $-10.05K
-0.001x +99.24%
2010-12-31 Nkr100.21 Million
≈ $10.54 Million
Nkr-13.46 Million
≈ $-1.42 Million
-0.134x -811.95%
2009-12-31 Nkr111.78 Million
≈ $11.76 Million
Nkr-1.65 Million
≈ $-173.31K
-0.015x +84.76%
2008-12-31 Nkr110.24 Million
≈ $11.60 Million
Nkr-10.66 Million
≈ $-1.12 Million
-0.097x -324.44%
2007-12-31 Nkr128.99 Million
≈ $13.57 Million
Nkr5.56 Million
≈ $584.83K
0.043x +124.42%
2006-12-31 Nkr60.87 Million
≈ $6.40 Million
Nkr-10.74 Million
≈ $-1.13 Million
-0.176x -144.73%
2005-12-31 Nkr43.19 Million
≈ $4.54 Million
Nkr-3.11 Million
≈ $-327.70K
-0.072x +62.10%
2004-12-31 Nkr19.03 Million
≈ $2.00 Million
Nkr-3.62 Million
≈ $-381.04K
-0.190x +68.79%
2003-12-31 Nkr7.21 Million
≈ $758.70K
Nkr-4.40 Million
≈ $-462.53K
-0.610x --

About Navamedic ASA

OL:NAVA Norway Medical Distribution
Market Cap
$28.14 Million
Nkr267.39 Million NOK
Market Cap Rank
#23829 Global
#220 in Norway
Share Price
Nkr11.15
Change (1 day)
+1.36%
52-Week Range
Nkr11.00 - Nkr26.00
All Time High
Nkr42.60
About

Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. Its product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. The company offers medical nutrition… Read more